STORY
1 day 7 outlets 9 reports running since 19.08

LATEST

Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations
finance.yahoo.com  ·  19.08.2026 23:58

HOW IT DEVELOPED

  1. Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread aljazeera.com  ·  19.08 22:39
  2. mRNA Vaccine Stocks Rise on Moderna-Merck Success wsj.com  ·  19.08 20:29
  3. This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results finance.yahoo.com  ·  19.08 19:10
  4. Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors. finance.yahoo.com  ·  19.08 18:54
  5. mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say arstechnica.com  ·  19.08 18:53
  6. Promising Results for mRNA Cancer Vaccine from Moderna and Merck time.com  ·  19.08 15:49
  7. Moderna share price doubles on melanoma vaccine trial success ft.com  ·  19.08 14:08
  8. Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today’s Market barrons.com  ·  19.08 13:35

More in this section

Kenya confirms its first Ebola death as outbreak spreadsbbc.co.uk · 06.10 Ten NHS trusts referred over monitoring consentbbc.co.uk · 06.10 'Life-saving' charity for mums faces closing supportbbc.co.uk · 06.10 Pennsylvania faces largest measles outbreak in decades as case count rises to 1,000theguardian.com · 05.10 Trump says US ready to aid Russia with plague outbreak in Siberiaaljazeera.com · 05.10 GP 10-minute appointment slots 'making it harder to do cancer checks'bbc.co.uk · 05.10

Other stories

Rusiya MN: Ukrayna son sutkada 1750 dron ilə hücum edibazerbaijan · apa.az ADY-nin sərnişin daşımaları artıb azerbaijan · modern.az Narqis Vik: "Orta Dəhliz investisiya-sənaye əməkdaşlığı platforması olmalıdır"azerbaijan · report.az Stiv Loris Gi-Dibi: "Azərbaycan ortamüddətli perspektivdə dinamik iqtisadi artım üçün baza yaradır"azerbaijan · report.az Güc, pul, ambisiya və xəyanət – Sem Altmanın hekayəsi Hollivuddaculture · kulis.az The S&P 500 is facing rate chaos and narrow breadth. Why one Goldman Sachs insider is still bullish on stocks.finance · marketwatch.com